Cargando…

Efficacy of Treatment With PARP Inhibitor and Immunotherapy for Aggressive Adrenocortical Carcinomawith Cushing’s Syndrome Refractory to Treatment With EDP Chemotherapy and Mitotane

A 39-year-old female with a past medical history of Ehlers-Danlos syndrome, Celiac disease, Hashimoto’s hypothyroidism and germline BRCA mutation presented with abdominal pain and distension. CT imaging demonstrated innumerable bilateral pulmonary nodules concerning for metastases, paraoesophageal a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greb, Alexandra C, Reikes, Andrew R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Adrenal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265979/ http://dx.doi.org/10.1210/jendso/bvab048.261

Ejemplares similares

Investigating the Role of Cholesterol and Lipid Trafficking in Mitotane Resistance in Adrenocortical Carcinoma
por: Warde, Kate, et al.
Publicado: (2021)

ODP597 Clinical case of uncomplicated pregnancy in a patient with adrenocortical carcinoma during treatment with mitotane
por: Beltsevich, Dmitry, et al.
Publicado: (2022)

Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients
por: Terzolo, Massimo, et al.
Publicado: (2021)

SAT-LB064 Mitotane Induces Autophagy: A Mechanism to Promote Chemoresistance in Adrenocortical Carcinoma
por: Tompkins, Kenneth, et al.
Publicado: (2019)

SUN-216 Investigating the Role of the Liver X Receptor in Potentiating Mitotane Therapy in Adrenocortical Carcinoma
por: Warde, Kate, et al.
Publicado: (2020)

SUN-350 Sterol-O-Acyl Transferase 1 Protein Expression Alone Is Not Sufficient to Predict Response to Mitotane Treatment in Adrenocortical Carcinoma
por: Weigand, Isabel, et al.
Publicado: (2019)

PSAT024 A Case of Mild Autonomous Cortisol Secretion Managed with Active Surveillance
por: Thakkar, Aditi, et al.
Publicado: (2022)

ODP049 Oncocytic adrenocortical carcinoma misdiagnosed as renal oncocytoma and use of urinary steroid profiling in disease monitoring after mitotane therapy
por: Wong, Cheuk Lik, et al.
Publicado: (2022)

SAT-158 New Data on High Prevalence and Time of Occurrence of New Onset Hypothyroidism Associated with Mitotane Therapy in a Cohort of Adrenocortical Cancer
por: Poirier, Jonathan, et al.
Publicado: (2020)

THU609 Timeline For Undetectable Mitotane Plasma Levels In Adrenocortical Carcinoma Patients After Stopping Treatment
por: Younes, Nada, et al.
Publicado: (2023)

LBSAT63 Cushing Syndrome As A Presentation Of Adrenocortical Carcinoma.Case Report
por: Eid, Mennaallah, et al.
Publicado: (2022)

SUN-169 A Rare Case of Adrenocortical Carcinoma Presenting as Hyperaldosteronism Combined with Cushing’s Syndrome
por: Punni, Emma, et al.
Publicado: (2020)

SUN-198 Metastatic Progression of Adrenocortical Carcinoma: Phenotypic Transformation to ACTH-Independent Cushing’s Syndrome
por: Ocampo, Javier, et al.
Publicado: (2020)

SUN-349 Prognostic Metabolic Signature in Aggressive Adrenocortical Carcinoma
por: Tirosh, Amit, et al.
Publicado: (2019)

SUN-379 Transformation of Adrenal Adenoma into Adrenocortical Carcinoma in a Cushing Syndrome Patient after Surgery
por: Barsukova, Yuliya, et al.
Publicado: (2019)

PSAT025 Functional Adrenocortical Oncocytic Neoplasm: A Rare Cause of ACTH Independent Cushing's Syndrome
por: Chang, Alan, et al.
Publicado: (2022)

SUN-351 Are We Underestimating The Role Of Systemic Chemotherapy In The Treatment Of Localized And Advanced Adrenocortical Carcinoma?
por: Ferreira, Amanda, et al.
Publicado: (2019)

MON-LB061 Cushing Syndrome Due to an Adrenocortical Carcinoma in a Baby with Atypical Beckwith-Wiedemann Syndrome
por: Bereket, Abdullah, et al.
Publicado: (2019)

THU617 Prolonged Exposure To Target Mitotane Concentrations Is Associated With Better Recurrence-free Survival In Patients With Adrenocortical Carcinoma On Adjuvant Treatment
por: Puglisi, Soraya, et al.
Publicado: (2023)

FRI199 Severe Hypertriglyceridemia And Acute Pancreatitis In A Patient With Adrenocortical Carcinoma (ACC) Taking Mitotane
por: Cortez, Briana Noel, et al.
Publicado: (2023)

EDP-mitotane in children: reassuring evidence of reversible side-effects and neurotoxicity
por: Steenaard, Rebecca V., et al.
Publicado: (2022)

OR12-1 Activity of Abiraterone Acetate in the management of Cushing syndrome associated to advanced adrenocortical carcinoma: results of the ABACUS trial.
por: Abate, Andrea, et al.
Publicado: (2022)

PSAT096 Development and Validation of Mitotane Determination in Plasma Samples by LC-DAD
por: Lima-Valassi, Helena P, et al.
Publicado: (2022)

Mitotane in adrenocortical carcinoma.
por: Vassilopoulou-Sellin, R., et al.
Publicado: (1994)

SAT-212 Management of VHL-Associated Pheochromocytoma in Pregnancy
por: Reikes, Andrew Reed, et al.
Publicado: (2020)

Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer
por: Head, Lia, et al.
Publicado: (2019)

SAT-LB34 Repressive Epigenetic Programs Reinforce Steroidogenic Differentiation and Wnt/β-Catenin Signaling in Aggressive Adrenocortical Carcinoma
por: Mohan, Dipika R, et al.
Publicado: (2020)

Thymic Hyperplasia Developing After Treatment of Cushing’s Syndrome, Management and Literature Review
por: Riaz, Aiman, et al.
Publicado: (2021)

The Improvement in Hepatic Steatosis After Cushing’s Syndrome Treatment Is an Early Sign of Metabolic Recovery
por: Hamimi, Ahmed, et al.
Publicado: (2021)

PSUN42 New-Onset Rheumatoid Arthritis After Surgical Treatment of Cushing Syndrome
por: Richstein, Ryan, et al.
Publicado: (2022)

PSAT002 Unilateral Adrenalectomy as a Treatment Option in Patient with Cyclical Cushing's Syndrome
por: Gosmanov, Aidar, et al.
Publicado: (2022)

Adrenocortical Carcinoma Treatment in the Netherlands: An Analysis From the Netherlands Cancer Registry From 2014 to 2019
por: Steenaard, Rebecca, et al.
Publicado: (2021)

EDP-M plus sintilimab in the treatment of adrenocortical carcinoma: a case report
por: Zhang, Zhipeng, et al.
Publicado: (2022)

Cushing's syndrome, pheochromocytoma, or both?
por: Kullamaa, Liisa, et al.
Publicado: (2023)

SUN-199 A Case of Ectopic Cushing’s Syndrome with Major Complications Leading to Treatment Dilemmas
por: McCloskey, Karen, et al.
Publicado: (2020)

Excellent Maternal and Fetal Outcomes Associated With Early Detection and Treatment of Cushing’s Syndrome During Pregnancy
por: Wang, Ally W, et al.
Publicado: (2021)

Cushing Syndrome in the Setting of Chronic Dilated Cardiomyopathy: Can Treatment Improve Chronic Dilated Cardiomyopathy?
por: Pathak, Leilani, et al.
Publicado: (2021)

High‐Dose Mitotane‐Induced Encephalopathy in the Treatment of Adrenocortical Carcinoma
por: Pape, Elise, et al.
Publicado: (2017)

A Case of Iatrogenic Cushing’s Syndrome
por: Del Toro Diez, Andrea, et al.
Publicado: (2021)

Unusual Presentation of Cyclic Cushing’s Syndrome
por: Morales Hernandez, Maria del Mar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1p50de7kqgbgk048mhp0kec28d